- Home
- CNTX vs CNTN Comparison
CNTX vs CNTN Comparison
Compare CNTX & CNTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.88
N/A
Current Price
$4.65
Company Overview
Basic Information| Metric | CNTX | CNTN |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.5M | 176.6M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CNTX | CNTN |
|---|---|---|
| Price | $2.88 | $4.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 608.7K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 69.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.49 | $4.43 |
| 52 Week High | $3.30 | $5.27 |
Technical Indicators
Market Signals| Indicator | CNTX | CNTN |
|---|---|---|
| Relative Strength Index (RSI) | 65.86 | 45.31 |
| Support Level | $2.07 | N/A |
| Resistance Level | N/A | $5.27 |
| Average True Range (ATR) | 0.23 | 0.36 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 69.26 | 36.87 |
Price Performance
Historical Comparison CNTX
CNTN
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.